ArticleJAMA2016
Reducing Adverse Drug Events: The Need to Rethink Outpatient Prescribing.
Article in JAMA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review.Frontiers in pharmacology · 2023Review
- A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts.Translational psychiatry · 2022Article
- The Abrupt Expansion of Ambulatory Telemedicine: Implications for Patient Safety.Journal of general internal medicine · 2022Review
- Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.Therapeutic advances in drug safety · 2022Article
- Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study).Internal and emergency medicine · 2021Article
- Evaluation of a Revised Home Medication Experience Questionnaire (HOME-Qv2).Pharmacy (Basel, Switzerland) · 2020Article
- Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes.Journal of psychiatric research · 2020Article
- Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.Journal of managed care & specialty pharmacy · 2019Article
- Community-acquired and hospital-acquired medication harm among older inpatients and impact of a state-wide medication management intervention.BMJ quality & safety · 2019Article
- Anticoagulation Across Care Transitions: Identifying Minimum Data to Maximize Drug Safety.Joint Commission journal on quality and patient safety · 2018Article
- A dataset quantifying polypharmacy in the United States.Scientific data · 2017Article
- Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.